Miromatrix Medical Inc.
MIRODelisted Dec 13, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001527096
Miromatrix Medical Inc. was delisted on Dec 13, 2023; its insiders filed their last Form 4 on Dec 13, 2023; 32 institutions reported holding it in 13F filings for Q3 2023, worth $8.78M in total; no superinvestor held it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 32
- Q3 2023, 0 vs. previous quarter
- 13F value
- $8.78M
- Reported value at the end of Q3 2023
- Superinvestors holding
- 0
- At the end of Q3 2023
Superinvestors holding MIRO, Q3 2023
No superinvestor reported holding MIRO at the end of Q3 2023.
Latest insider trades
Open-market purchases and sales by Miromatrix Medical Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Douglas James MichaelCHIEF FINANCIAL OFFICER | PPurchase | +31.3K | $1.60 | +$50.0K | +156.3%51.3K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Ross Jeffrey JamesCHIEF EXECUTIVE OFFICER | PPurchase | +31.3K | $1.60 | +$50.0K | +8.6%396.3K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Barry John JosephVICE PRESIDENT OF R&D | PPurchase | +6.25K | $1.60 | +$10.0K | +21.4%35.5K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Buckman PaulDirector | PPurchase | +31.3K | $1.60 | +$50.0K | +146.4%52.6K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Maag PeterDirector | PPurchase | +31.3K | $1.60 | +$50.0K | +89.3%66.3K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Erb John LDirector | PPurchase | +31.3K | $1.60 | +$50.0K | +125.0%56.3K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Burke William P. Mr.Director | PPurchase | +31.3K | $1.60 | +$50.0K | +63.9%80.2K after | |
| Mar 30, 2023 (view filing) | Mar 10 | 20 daysLate | Heine Lisa WippermanDirector | PPurchase | +31.3K | $1.60 | +$50.0K | +63.9%80.2K after |
Top 10 13F holders, Q3 2023
The largest institutional positions in Miromatrix Medical Inc. at the end of Q3 2023; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| First Light Asset Management, LLC | 2,278,670 | $2.99M | 0.28% | +52,930+2.4% | Added |
| Gagnon Securities LLC | 1,458,351 | $1.91M | 0.48% | +16,937+1.2% | Added |
| Vanguard Group Inc | 658,548 | $862.7K | 0.00% | +9,293+1.4% | Added |
| Gagnon Advisors, LLC | 556,755 | $729.3K | 0.61% | 00.0% | Unchanged |
| RTW Investments, LP | 445,222 | $583.2K | 0.01% | 00.0% | Unchanged |
| Mayo Clinic | 191,622 | $251.0K | 0.48% | 00.0% | Unchanged |
| G2 Investment Partners Management LLC | 168,723 | $221.0K | 0.05% | −12,077−6.7% | Reduced |
| Geode Capital Management, LLC | 173,776 | $210.3K | 0.00% | −14,000−7.5% | Reduced |
| Sweet Financial Partners, LLC | 139,553 | $182.8K | 0.05% | +1,988+1.4% | Added |
| Perkins Capital Management Inc | 119,320 | $156.0K | 0.15% | 00.0% | Unchanged |